Comparison of robotic-assisted surgery outcomes with laparotomy for endometrial cancer staging in Turkey

Archives of Gynecology and Obstetrics
Ahmet GöçmenMustafa Gazi Uçar

Abstract

To compare the results of patients on whom staging was applied by robotic-assisted laparoscopic surgery and laparotomy for endometrial cancer. The study included 10 patients who had undergone robotic-assisted endometrial staging (group 1) and 12 patients staged by open surgery (group 2). Demographical characteristics and operative outcomes of all patients were compared. Body mass index, age, previous abdominal surgeries, histopathologic characteristics, performed operative procedure, operation time, complications, hospitalization duration, estimated blood loss and number of resected lymph nodes were recorded for all patients. Mean age of the patients in the robotic surgery group was 55.7 years (37-66) and in the laparotomy group 56.4 years (47-75). Body mass index was calculated as 32.7 kg/m² (24.5-40.3) in group 1 and 30.3 kg/m² (25.9-35.8) in group 2. Total duration of operation was 234.6 min (137-300) and 168.5 min (102-232) in group 1 and 2, respectively. Mean duration of hospitalization in group 1 was 2.8 days (2-5) and in group 2 was 8.8 days (6-13). Estimates of blood loss were 95 ml (20-210 ml) in the robotic surgery group and 255 ml (80-420) in the other group. The mean number of resected lymph nodes was 42 (13-86) and...Continue Reading

References

Oct 1, 1993·Gynecologic Oncology·J M ChildersE A Surwit
Jan 10, 2004·The Surgical Clinics of North America·Nicholas Stylopoulos, David Rattner
Feb 27, 2004·Gynecologic Oncology·Andreas ObermairAnthony J McCartney
Jun 25, 2005·Current Opinion in Obstetrics & Gynecology·Javier F Magrina
Aug 9, 2005·Lancet·Frederic AmantIgnace Vergote
Nov 11, 2005·The Journal of Urology·Charles D ScalesDavid M Albala
Sep 12, 2006·Gynecologic Oncology·Mario E BeinerUNKNOWN Hereditary Ovarian Cancer Clinical Study Group
Nov 28, 2008·Obstetrics and Gynecology·Leigh G SeamonJeffrey M Fowler
May 16, 2009·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Martin K Oehler
May 21, 2009·The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS·Anna V HoekstraM Patrick Lowe
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 23, 2009·Obstetrics and Gynecology·M Patrick LoweTodd D Tillmanns
Jul 23, 2009·Obstetrics and Gynecology·Barbara L RobinsonThomas C Randall

❮ Previous
Next ❯

Citations

May 29, 2012·International Urogynecology Journal·O E O'Sullivan, B A O'Reilly
Nov 30, 2011·Current Opinion in Obstetrics & Gynecology·Ga Won Yim, Young Tae Kim
Dec 23, 2011·Obstetrics and Gynecology International·Lori WeinbergPedro F Escobar
May 8, 2014·Journal of Gynecologic Surgery·Abeer EddibPankaj Singhal
Jan 8, 2013·Archives of Gynecology and Obstetrics·Michelle O'NeillMáirín Ryan
Jul 22, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D A ParkS H Lee
Sep 20, 2016·American Journal of Obstetrics and Gynecology·Toni PicernoPedro T Ramirez
May 29, 2019·Seminars in Ophthalmology·Swathi KalikiDilip K Mishra
Jan 18, 2015·The British Journal of Ophthalmology·Xinan ShengJun Guo
Dec 4, 2020·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A KakkosF Goffin
Jul 8, 2011·Current Opinion in Obstetrics & Gynecology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.